Analgesic Activity of Benzofurans and Indoles
Analgesic Activity of Benzofurans and Indoles
dure6. First we decided to prepare 1a to prove the reported activity. The de-
scribed methods of preparation of xanthoxyline are mostly nonselective
and include the Friedel–Crafts acetylation of 3,5-dimethoxyphenole7 or
methylation of 1-(2,4,6-trihydroxyphenyl)ethan-1-one8,9 under various
conditions. Demethylation of 1-(2,4,6-trimethoxyphenyl)ethan-1-one with
aluminum chloride is also nonselective providing a mixture of all possible
mono-, di-, and trihydroxy derivatives10. We applied a published proce-
dure11 of selective demethylation of ortho-methoxy aromatic ketones. This
procedure monodemethylated 1-(2,4,6-trimethoxyphenyl)ethan-1-one to
give acceptable yields of xanthoxyline. This compound treated with
2-bromo-1-(4-bromophenyl)ethan-1-one in the presence of potassium hy-
droxide provided 1a. Since the reported analgesic activity of 1a was proved,
compounds 1b–1d were prepared from the corresponding 1-(2-hydroxy-
phenyl)ethan-1-ones by the same procedure. Similarly, starting from
2-hydroxy-4,6-dimethoxybenzaldehyde and the corresponding 2-bromo-
1-phenylethan-1-ones, compounds 1e and 1f were prepared. In this case, the
use of potassium carbonate in butan-2-one under reflux was sufficient for a
smooth reaction.
Analgesic screening found compound 1a the most active of the series.
However, all these compounds were found active only for i.p. or s.c. appli-
cation and only slightly active or inactive after p.o. application. In order to
obtain compounds with better pharmacological profile, we decided to pre-
pare some more different analogs of 1a. First we decided to prepare
3-amino-substituted 1-benzofurans 2, 1-benzothiophenes 3, and indoles 4,
since we expected that these compounds could form water-soluble salts.
R1
R3 R2 NH2 NH2
R
MeO O O X O O O
1 R1 R2 R3
a Br Me MeO 2, X = O 12 R
b H Me MeO 3, X = S a Me
c Br Me H 4, X = NR b OEt
d H Me H
e Br H MeO
f H H MeO
R1
CN R4
1
R R1 NH2
R2 OH CN R4
R3
5
R2 O R2 O O
+ O
R3 O
Br 7 R3 2
2, 7 R1 R2 R3 R4
R4 6 a H H H H
b H H H Br
c H H H Ph
5 R1 R2 R3 6 R4
d H H H 2,4-F2C6H3
a H H H a H e H H MeO H
b H H MeO b Br f H H MeO Br
c MeO MeO H c Ph g H H MeO Ph
d 2,4-F2C6H3 h H H MeO 2,4-F2C6H3
i MeO MeO H H
j MeO MeO H Br
k MeO MeO H Ph
l MeO MeO H 2,4-F2C6H3
SCHEME 1
O CN R
CN
Br
+
SH S
R O
8 6 R R
a H
b Br NH2
3 R
a H
b Br S O
SCHEME 2
CN O CN R2
+ Br
NH N
R1 R2 R1 O
10 4,10 R1 R2
9 R1 6 R2 a MeSO2 H
a MeSO2 a H b MeSO2 Br
b 4-Me-C6H4SO2 b Br c 4-Me-C6H4SO2 H
c CO2Et R R2 d 4-Me-C6H4SO2 Br
d MeCO e CO2Et H
NH2 NH2 f CO2Et Br
11 R
a H N O N O 4
b Br R1
H
SCHEME 3
EXPERIMENTAL
Melting points were measured on a Kofler block and are uncorrected. 1H NMR spectra were
recorded on a Bruker instrument (250 MHz). Chemical shifts are given in ppm (δ-scale), cou-
pling constants (J) in Hz. IR spectra (KBr) were recorded on a Unicam SP 2006 spectrometer,
wavenumbers are given in cm–1. UV spectra were measured on a Shimadzu UV-260 spec-
trometer in ethanol, wavelengths are given in nm. Flash chromatography was done on silica
gel 60 (230–400 mesh) and preparative TLC on pre-coated PLC plates (silica gel 60) from EM
Science.
The following starting compounds were prepared by the previously described methods:
1-(biphenyl-4-yl)-2-bromoethan-1-one19 (6c), 2-bromo-1-(2′,4′-difluorobiphenyl-4-yl)ethan-
1-one20 (6d), N-(2-cyanophenyl)methanesulfonamide21 (9a), N-(2-cyanophenyl)-4-methyl
benzenesulfonamide 22 (9b), ethyl N-(2-cyanophenyl)carbamate 23 (9c), and N-(2-cyano-
phenyl)acetamide24 (9d). The known 1-benzofurans 12a and 12b were prepared analogously
as described in the literature12,13.
TABLE I
Analgesic activitya of active compounds 1–4, 11
a
– p.o./s.c., 30 mg/kg.
1-(2-Hydroxy-4,6-dimethoxyphenyl)ethan-1-one
Butyllithium (10 ml of a 2.5 M solution in hexanes, 25 mmol) was added to a toluene solu-
tion (25 ml) of 1-methylpiperazine (2.5 g, 25 mmol) under argon at 0 °C and the mixture
was stirred at room temperature for 20 min. The mixture was cooled to 0 °C and a solution
of 1-(2,4,6-trimethoxyphenyl)ethan-1-one (4.2 g, 20 mmol) in toluene (50 ml) was added
dropwise keeping the temperature below 15 °C. After addition of butyllithium (10 ml of a
2.5 M solution in hexanes, 25 mmol), the mixture was stirred at room temperature for 30
min and then at 80 °C for 10 h. The cold mixture was quenched with 5% hydrochloric acid
(20 ml) and the aqueous layer was extracted with diethyl ether. The combined organic ex-
tracts were dried with magnesium sulfate, the residue after evaporation (2.7 g) was crystal-
lized twice from hexane to give the required product (2.7 g, 71%) as white crystals; m.p.
84–85 °C (ref. 25 87 °C). 1H NMR (CDCl3): 2.61 s, 3 H (CH3); 3.82 s, 3 H (CH3O); 3.85 s, 3 H
(CH3O); 5.92 d, 1 H, J = 2.5 (H-5); 6.06 d, 1 H, J = 2.5 (H-3); 14.01 s, 1 H (OH).
2-Hydroxy-3-methoxybenzonitrile (5b)
2-Hydroxy-4,6-dimethoxybenzonitrile (5c)
stirred at room temperature for 2 h. The mixture was poured into water (100 ml), the insolu-
ble portion was filtered off, washed with water and crystallized from ethanol to give pure 7.
2-(2-Oxo-2-phenylethoxy)benzonitrile (7a). Yield 83% (Method A), 79% (Method B); white
crystals, m.p. 147–148 °C (ref. 12 148–149 °C). For C 15H11NO2 (237.3) calculated: 75.94% C,
4.67% H, 5.90% N; found: 75.57% C, 4.74% H, 6.01% N. 1H NMR (CDCl3): 5.43 s, 2 H
(CH2); 6.83 d, 1 H, J = 8.5 (H-3); 7.03 dt, 1 H, J = 7.5, 1.0 (H-5); 7.54 m, 5 H (H-4, H-6, H-3′,
H-4′, H-5′); 8.01 bd, 2 H (H-2′, H-6′).
2-[2-(4-Bromophenyl)-2-oxoethoxy]benzonitrile (7b). Yield 57% (Method A); white crystals,
m.p. 141–150 °C (ref. 12 164–165 °C; crystallized from CHCl 3 –CCl 4 ). For C 15 H 10 BrNO 2
(316.1) calculated: 56.99% C, 3.19% H, 25.27% Br, 4.43% N; found: 56.67% C, 3.44% H,
24.89% Br, 4.57% N. IR (KBr): 1 692 (C=O), 2 223 (CN).
2-[2-(Biphenyl-4-yl)-2-oxoethoxy]benzonitrile (7c). Yield 82% (Method A); white crystals,
m.p. 148–151 °C. For C 21H15NO2 (313.4) calculated: 80.49% C, 4.82% H, 4.47% N; found:
80.19% C, 5.01% H, 4.43% N. IR (KBr): 1 688 (C=O), 2 226 (CN). UV, λ (log ε): 207 (4.72),
291 (4.52). 1H NMR (CDCl3): 5.44 s, 2 H (CH2); 6.85 d, 1 H, J = 7.8 (H-3); 7.02 dt, 1 H, J =
7.8, 1.6 (H-4); 7.46 m, 4 H (H-5, H-2′′, H-4′′, H-6′′); 7.57 dd, 1 H, J = 7.5, 1.6 (H-6); 7.62 bd,
2 H (H-3′′, H-5′′); 7.72 d, 2 H, J = 8.5 (H-3′, H-5′); 8.08 d, 2 H, J = 8.5 (H-2′, H-6′).
2-[2-(2′,4′-Difluorobiphenyl-4-yl)-2-oxoethoxy]benzonitrile (7d). Yield 49% (Method B); white
crystals, m.p. 141–143 °C. For C 21H13F2NO2 (349.3) calculated: 72.20% C, 3.75% H, 10.88% F,
4.01% N; found: 72.13% C, 4.09% H, 10.57% F, 3.57% N. 1H NMR (CDCl3): 5.44 s, 2 H
(CH2); 6.86 d, 1 H, J = 8.5 (H-3); 6.99 m, 3 H (H-5, H-3′′, H-5′′); 7.46 m, 2 H (H-4, H-6′′);
7.59 dd, 1 H, J = 7.9, 1.9 (H-6); 7.65 dd, 2 H, J = 8.5, 1.6 (H-3′, H-5′); 8.09 d, 2 H, J = 8.5
(H-2′, H-6′). 19F NMR (CDCl3): –109.68 (F-2′′), –113.21 (F-4′′).
3-Methoxy-2-(2-oxo-2-phenylethoxy)benzonitrile (7e). Yield 67% (Method B); white crystals,
m.p. 83–84 °C. For C 16H13NO3 (267.3) calculated: 71.90% C, 4.90% H, 5.24% N; found:
71.66% C, 4.68% H, 5.02% N. 1H NMR (CDCl3): 3.77 s, 3 H (CH3); 5.50 s, 2 H (CH2);
7.09–7.17 m, 3 H (H-4, H-5, H-6); 7.49 m, 2 H (H-3′, H-5′); 7.60 m, 1 H (H-4′); 7.97 m, 2 H
(H-2′, H-6′).
3-Methoxy-2-[2-(4-bromophenyl)ethoxy-2-oxo]benzonitrile (7f). Yield 79% (Method B); white
crystals, m.p. 132–133 °C. For C 16H12BrNO3 (346.2) calculated: 55.51% C, 3.49% H, 23.08%
Br, 4.05% N; found: 55.49% C, 3.68% H, 23.55% Br, 3.60% N. 1H NMR (CDCl3): 3.78 s, 3 H
(CH3); 5.41 s, 2 H (CH2); 7.09–7.17 m, 3 H (H-4, H-5, H-6); 7.63 d, 2 H, J = 8.7 (H-3′, H-5′);
7.86 d, 2 H, J = 8.7 (H-2′, H-6′).
2-[2-(Biphenyl-4-yl)-2-oxoethoxy]-3-methoxybenzonitrile (7g). Yield 87% (Method B); white
crystals, m.p. 122–125 °C. For C 22H17NO3 (343.4) calculated: 76.95% C, 4.99% H, 4.08% N;
found: 76.82% C, 5.33% H, 3.71% N. IR (KBr): 1 693 (C=O), 2 231 (CN). UV, λ (log ε): 208
(4.68), 289 (4.41). 1H NMR (CDCl3): 3.79 s, 3 H (CH3); 5.52 s, 2 H (CH2); 7.09–7.18 m, 3 H
(H-4, H-5, H-6); 7.45 m, 3 H (H-3′′, H-4′′, H-5′′); 7.63 m, 2 H (H-2′′, H-6′′); 7.71 d, 2 H, J =
8.3 (H-3′, H-5′); 8.06 d, 2 H, J = 8.3 (H-2′, H-6′).
2-[2-(2′,4′-Difluorobiphenyl-4-yl)-2-oxoethoxy]-3-methoxybenzonitrile (7h). Yield 77% (Method B);
white crystals, m.p. 126–128 °C. For C 22H15F2NO3 (379.4) calculated: 69.65% C, 3.99% H,
10.02% F, 3.69% N; found: 69.57% C, 4.24% H, 9.67% F, 3.51% N. IR (KBr): 1 674 (C=O),
232 (CN). UV, λ (log ε): 209 (4.72), 282 (4.30). 1H NMR (CDCl3): 3.80 s, 3 H (CH3); 5.51 s,
2 H (CH2); 6.97 m, 2 H (H-3′′, H-5′′); 7.10–7.18 m, 3 H (H-4, H-5, H-6); 7.44 m, 1 H (H-6′′);
7.63 dd, 2 H, J = 8.8, 1.6 (H-3′, H-5′); 8.06 d, 2 H, J = 8.8 (H-2′, H-6′). 19F NMR (CDCl3):
–109.76 (F-2′′), –113.19 (F-4′′).
Sodium methoxide (0.55 g, 10 mmol) was added to a stirred solution of 7 (10 mmol) in
methanol (20 ml) and the mixture was stirred at room temperature for 30 min. The mixture
was poured into water (25 ml), the insoluble portion was filtered off, washed with water and
crystallized from ethanol to give 2.
2-Benzoyl-1-benzofuran-3-amine (2a). Yield 89%; yellow crystals, m.p. 124–126 °C (ref. 12
125–126 °C). For C 15 H 11 NO 2 (237.3) calculated: 75.94% C, 4.67% H, 5.90% N; found:
76.11% C, 4.53% H, 5.97% N. IR (KBr): 1 621 (C=O); 3 296, 3 422 (NH2). UV, λ (log ε): 208
(4.13), 252 (4.23), 312 (3.99), 380 (4.26).
2-(4-Bromobenzoyl)-1-benzofuran-3-amine (2b). Yield 90%; yellow crystals, m.p. 198–200°C
(ref.12 203–204 °C). For C 15H10BrNO2 (316.1) calculated: 56.99% C, 3.19% H, 25.27% Br,
4.43% N; found: 56.90% C, 3.26% H, 24.88% Br, 4.03% N. IR (KBr): 1 613 (C=O); 3 297,
3 420 (NH2). UV, λ (log ε): 203 (4.32), 221 (4.10), 357 (4.28), 314 (3.98), 385 (4.33). 1H NMR
(CDCl3, 60 °C): 5.83 bs, 2 H (NH2); 7.30 m, 1 H (H-5); 7.47 m, 1 H (H-7); 7.56 m, 1 H (H-6);
7.65 m, 1 H (H-4); 7.69 d, 2 H, J = 8.8 (benzoyl); 8.17 d, 2 H, J = 8.8 (benzoyl).
2-(Biphenyl-4-ylcarbonyl)-1-benzofuran-3-amine (2c). Yield 87%; yellow crystals, m.p.
167–169 °C. For C 21H15NO2 (313.4) calculated: 80.49% C, 4.82% H, 4.47% N; found: 80.38% C,
5.00% H, 4.29% N. IR (KBr): 1 615 (C=O); 3 316, 3 418 (NH2). UV, λ (log ε): 206 (4.56), 226
(4.19), 249 (4.12), 295 (4.22), 387 (4.31). 1H NMR (CDCl3, 60 °C): 6.01 bs , 2 H (NH2);
7.22 m, 1 H (H-5); 7.41 m, 4 H (H-6, H-7, H-3′′, H-4′′, H-5′′); 7.61 m, 3 H (H-4, H-2′′, H-6′′);
7.72 d, 2 H, J = 8.2 (H-3′, H-5′); 8.33 d, 2 H, J = 8.2 (H-2′, H-6′).
2-[(2′,4′-Difluorobiphenyl-4-yl)carbonyl]-1-benzofuran-3-amine (2d). Yield 51%; yellow crys-
tals, m.p. 173–176 °C. For C 21H13F2NO2 (349.3) calculated: 72.20% C, 3.75% H, 10.88% F,
4.01% N; found: 72.13% C, 4.02% H, 10.98% F, 3.75% N. IR (KBr): 1 613 (C=O); 3 304,
3 406 (NH2). UV, λ (log ε): 204 (4.57), 224 (4.22), 258 (4.24), 284 (4.18), 386 (4.33). 1H NMR
(CDCl3, 60 °C): 6.03 bs, 2 H (NH2); 6.94 m, 2 H (H-3′′, H-5′′); 7.24 bt, 1 H (H-5); 7.46 m, 3 H
(H-6, H-7, H-6′′); 7.63 m, 3 H (H-4, H-3′, H-5′); 8.33 d, 2 H, J = 8.2 (H-2′, H-6′). 19F NMR
(CDCl3): –110.91 (F-2′′), –113.06 (F-4′′).
2-Benzoyl-7-methoxy-1-benzofuran-3-amine (2e). Yield 75%; yellow crystals, m.p. 166–168 °C.
For C16H13NO3 (267.3) calculated: 71.90% C, 4.90% H, 5.24% N; found: 71.99% C, 5.01% H,
5.26% N. IR (KBr): 1 621 (C=O); 3 316, 3 442 (NH2). UV, λ (log ε): 204 (4.39), 251 (4.34),
319 (3.90), 380 (4.25). 1H NMR (CDCl3): 3.99 s, 3 H (CH3); 6.01 bs, 2 H (NH2); 6.96 dd, 1 H,
J = 6.8, 2.0 (H-6); 7.16 m, 2 H (H-4, H-5); 7.49 dd, 3 H, J = 5.2, 1.9 (H-3′, H-5′); 8.27 m, 2 H
(H-2′, H-6′).
2-(4-Bromobenzoyl)-7-methoxy-1-benzofuran-3-amine (2f). Yield 64%; yellow crystals, m.p.
201–204°C. For C 16H12BrNO3 (346.2) calculated: 55.51% C, 3.49% H, 23.08% Br, 4.05% N;
found: 55.30% C, 3.60% H, 23.27% Br, 3.88% N. IR (KBr): 1 620 (C=O); 3 322, 3 440 (NH2).
1
H NMR (CDCl3, 60 °C): 4.01 s, 3 H (CH3); 5.94 bs, 2 H (NH2); 6.98 m, 1 H (H-6); 7.18 m, 2 H
(H-4, H-5); 7.65 d, 2 H, J = 7.9 (H-3′, H-5′); 8.16 d, 2 H, J = 7.9 (H-2′, H-6′).
2-(Biphenyl-4-ylcarbonyl)-7-methoxy-1-benzofuran-3-amine (2g). Yield 92%; yellow crystals,
m.p. 208–210 °C. For C 22H17NO3 (343.4) calculated: 76.95% C, 4.99% H, 4.08% N; found:
77.27% C, 5.39% H, 3.92% N. 1H NMR (CDCl3): 4.03 s, 3 H (CH3); 5.99 bs, 2 H (NH2); 7.00 m,
1 H (H-6); 7.20 m, 2 H (H-4, H-5); 7.39 tt, 1 H (H-4′′); 7.48 m, 2 H (H-3′′, H-5′′); 7.68 m, 2 H
(H-2′′, H-6′′); 7.76 bd, 2 H, J = 8.6 (H-3′, H-5′); 8.37 bd, 2 H, J = 8.6 (H-2′, H-6′).
2-[(2′,4′-difluorobiphenyl-4-yl)carbonyl]-7-methoxy-1-benzofuran-3-amine (2h). Yield 97%; yel-
low crystals, m.p. 178–180 °C. For C 22H15F2NO3 (379.4) calculated: 69.65% C, 3.99% H,
10.02% F, 3.69% N; found: 69.27% C, 4.22% H, 9.79% F, 3.49% N. IR (KBr): 1 617 (C=O);
3 348, 3 449 (NH2). UV, λ (log ε): 204 (4.58), 253 (4.22), 281 (4.22), 321 (3.92), 387 (4.34).
1
H NMR (CDCl3, 60 °C): 4.03 s, 3 H (CH3); 6.02 bs, 2 H (NH2); 6.96 m, 2 H (H-3′′, H-5′′);
7.00 m, 1 H (H-6); 7.20 m, 2 H (H-4, H-5); 7.48 m, 1 H (H-6′′); 7.67 bdd, 2 H, J = 8.5, 1.6
(H-3′, H-5′); 8.36 bd, 2 H, J = 8.5 (H-2′, H-6′). 19F NMR (CDCl3): –110.98 (F-2′′), –113.28
(F-4′′).
2-Benzoyl-4,6-dimethoxy-1-benzofuran-3-amine (2i). Yield 92%; yellow crystals, m.p.
112–113 °C. For C 17H15NO4 (297.3) calculated: 68.68% C, 5.09% H, 4.71% N; 68.54% C,
5.27% H, 4.73% N. IR (KBr): 1 624 (C=O); 3 333, 3 435 (NH2). UV, λ (log ε): 204 (4.44), 255
(4.20), 311 (3.90), 384 (4.41). 1H NMR (CDCl3, 60 °C): 3.83 s , 3 H (CH3O); 3.92 s, 3 H
(CH3O); 6.20 d, 1 H, J = 1.6 (H-5); 6.39 bs, 2 H (NH2); 6.47 d, 1 H, J = 1.6 (H-7); 7.47 m, 3 H
(benzoyl); 8.17 m, 2 H (benzoyl).
2-(4-Bromobenzoyl)-4,6-dimethoxy-1-benzofuran-3-amine (2j). Yield 95%; yellow crystals,
m.p. 225–226 °C. For C 17H14BrNO4 (376.2) calculated: 54.28% C, 3.75% H, 21.24% Br,
3.72% N; found: 54.56% C, 3.85% H, 21.06% Br, 3.66% N. IR (KBr): 1 624 (C=O); 3 331,
3 452 (NH2). UV, λ (log ε): 204 (4.37), 259 (4.17), 312 (3.84), 388 (4.35). 1H NMR (CDCl3):
3.84 s, 3 H (CH3); 3.92 s, 3 H (CH3); 6.20 d, 1 H, J = 1.9 (H-5); 6.42 bs, 2 H (NH2); 6.46 d,
1 H, J = 1.9 (H-7); 7.60 d, 2 H, J = 8.5 (H-3′, H-5′); 8.06 d, 2 H, J = 8.5 (H-2′, H-6′).
2-(Biphenyl-4-ylcarbonyl)-4,6-dimethoxy-1-benzofuran-3-amine (2k). Yield 75%; yellow crys-
tals, m.p. 177–183 °C. For C 23H19NO4 (373.4) calculated: 73.98% C, 5.13% H, 3.75% N;
found: 73.94% C, 5.20% H, 4.02% N. IR (KBr): 1 624 (C=O); 3 333, 3 456 (NH2). UV, λ (log ε):
205 (4.77), 224 (4.29), 260 (4.20), 285 (4.35), 391 (4.37). 1H NMR (CDCl3, 60 °C): 3.86 s, 3 H
(CH3); 3.98 s, 3 H (CH3); 6.20 d, 1 H, J = 1.8 (H-5); 6.44 bs, 2 H (NH2); 6.50 d, 1 H, J = 1.8
(H-7); 7.34–7.52 m, 3 H (H-3′, H-5′, H-4′′); 7.65–7.82 m, 4 H (H-2′′, H-3′′, H-5′′, H-6′′);
8.28 bd, 2 H, J = 8.4 (H-2′, H-6′).
2-[(2′,4′-Difluorobiphenyl-4-yl)carbonyl]-4,6-dimethoxy-1-benzofuran-3-amine (2l). Yield 55%;
yellow crystals, m.p. 199–201 °C. For C 23H17F2NO4 (409.4) calculated: 67.48% C, 4.19% H,
9.28% F, 3.42% N; found: 67.18% C, 4.15% H, 9.26% F, 3.10% N. IR (KBr): 1 628 (C=O);
3 326, 3 428 (NH2). UV, λ (log ε): 205 (4.55), 261 (4.28), 278 (4.28), 390 (4.42). 1H NMR
(CDCl3, 60 °C): 3.85 s, 3 H (CH3); 3.94 s, 3 H (CH3); 6.43 bs, 2 H (NH2); 6.22 d, 1 H, J = 1.9
(H-5); 6.49 d, 1 H, J = 1.9 (H-7); 6.94 m, 2 H (H-3′′, H-5′′); 7.45 m, 1 H (H-6′′); 7.61 dd, 2 H,
J = 8.2, 1.6 (H-3′, H-5′); 8.26 d, 2 H, J = 8.2 (H-2′, H-6′). 19F NMR (CDCl3): –111.30 (F-2′′),
–113.17 (F-4′′).
2-(Benzylsulfanyl)benzonitrile
2-Sulfanylbenzonitrile (8)
Sodium hydride (0.5 g, 50% dispersion in mineral oil, 10 mmol) was added to a solution of
2-sulfanylbenzonitrile (8) (10 mmol) in DMF (30 ml) and the mixture was stirred under ar-
gon for 1 h. Then a solution of an appropriate 2-bromo-1-phenylethan-1-one 6 (10 mmol)
was added and the mixture was stirred at room temperature for 24 h. The mixture was
poured into water (250 ml), the insoluble portion was filtered off, washed with water and
crystallized from ethanol.
2-Benzoyl-1-benzothiophen-3-amine (3a). Yield 52%; yellow crystals, m.p. 124–125 °C (ref. 15
gives a different m.p. 103–104 °C). For C 15H11NOS (253.3) calculated: 71.12% C, 4.38% H,
5.53% N, 12.66% S; found: 71.28% C, 4.77% H, 5.47% N, 12.49% S. IR (KBr): 1 598 (C=O);
3 321, 3 433 (NH2). UV, λ (log ε): 204 (4.40), 279 (4.18), 310 (3.84), 319 (3.92), 404 (4.00).
1
H NMR (CDCl3): 7.04 bs, 2 H (NH2); 7.35 td, 1 H, J = 7.3, 1.2 (H-4′); 7.43–7.53 m, 4 H
(H-2′, H-3′, H-5′, H-6′); 7.70 m, 2 H (H-5, H-6); 7.98 dd, 2 H, J = 7.3, 1.5 (H-4, H-7).
2-(4-Bromobenzoyl)-1-benzothiophen-3-amine (3b). Yield 41%; yellow crystals, m.p. 119–124 °C.
For C15H10BrNOS (332.2) calculated: 54.23% C, 3.03% H, 24.05% Br, 4.22% N, 9.65% S;
found: 54.55% C, 3.17% H, 24.48% Br, 4.07% N, 9.58% S. IR (KBr): 1 602 (C=O); 3 318,
3 430 (NH2). UV, λ (log ε): 205 (4.33), 274 (4.11), 322 (3.82), 404 (4.12). 1H NMR (CDCl3):
7.05 bs, 2 H (NH2); 7.37–7.50 m, 2 H (H-2′, H-6′); 7.60–7.69 m, 4 H (arom. H, H-3′, H-5′);
7.75 m, 2 H (arom. H).
Sodium hydride (0.5 g, 50% dispersion in mineral oil, 10 mmol) was added to a stirred
N-substituted 2-aminobenzonitrile 9 (10 mmol) in DMF (30 ml) and the mixture was stirred
for 1 h. Then a solution of an appropriate 2-bromo-1-phenylethan-1-one 6 (10 mmol) was
added and the mixture was stirred at room temperature for 2–24 h (TLC). The mixture was
poured into water (250 ml), the insoluble portion was filtered off, washed with water and
crystallized from a suitable solvent.
N-(2-Cyanophenyl)-N-(2-oxo-2-phenylethyl)methanesulfonamide (10a). Yield 86%; white crys-
tals, m.p. 189–192 °C (ethanol). For C 16H14N2O3S (314.4) calculated: 61.13% C, 4.49% H,
8.91% N, 10.20% S; found: 61.55% C, 4.32% H, 8.68% N, 9.92% S. IR (KBr): 1 153, 1 340 (SO2);
1 709 (C=O); 2 237 (CN). UV, λ (log ε): 204 (4.52), 243 (4.18). 1H NMR (CDCl3): 3.25 s, 3 H
(CH3); 5.28 s, 2 H (CH2); 7.48 m, 3 H (arom. H); 7.62–7.75 m, 3 H (arom. H); 7.93 d, 2 H, J =
7.5 (H-2, H-6, benzoyl); 8.00 d, 1 H, J = 8.5 (H-3, cyanophenyl).
N-[2-(4-Bromophenyl)-2-oxoethyl]- N-(2-cyanophenyl)methanesulfonamide (10b). Yield 88%;
white crystals, m.p. 154-159 °C (ethanol). For C 16H13BrN2O3S (393.2) calculated: 48.87% C,
3.33% H, 20.32% Br, 7.12% N, 8.15% S; found: 48.44% C, 3.21% H, 20.72% Br, 6.87% N,
7.76% S. IR (KBr): 1 158, 1 345 (SO2); 1 733 (C=O); 2 241 (CN). UV, λ (log ε): 205 (4.44),
248 (4.02). 1H NMR (CDCl3, 60 °C): 3.21 s, 3 H (CH 3); 5.20 s, 2 H (CH2); 7.46 dt, 1 H, J =
7.5, 1.3 (H-4, cyanophenyl); 7.61 d, 2 H, J = 8.8 (H-3, H-5, benzoyl); 7.67 m, 2 H (H-5, H-6,
cyanophenyl); 7.78 d, 2 H, J = 8.8 (H-2, H-6, benzoyl); 7.94 bd, 1 H (H-3, cyanophenyl).
N-(2-Cyanophenyl)-N-(2-oxo-2-phenylethyl)-4-methylbenzene-1-sulfonamide (10c). Yield 44%;
white crystals, m.p. 146–148 °C (methanol). For C 22H18N2O3S (390.5) calculated: 67.68% C,
4.65% H, 7.17% N, 8.21% S; found: 67.33% C, 4.91% H, 7.03% N, 8.05% S. IR (KBr): 1 162,
1 345 (SO2); 1 697 (C=O); 2 229 (CN). 1H NMR (CDCl3): 2.44 s, 3 H (CH3); 5.24 s, 2 H
(CH2); 7.30 d, 2 H, J = 8.05 (H-3, H-5); 7.40 m, 1 H (H-5, cyanophenyl); 7.48 d, 2 H, J = 8.05
(H-2, H-6); 7.60 m, 5 H (H-4, H-6, cyanophenyl; H-3, H-4, H-5, benzoyl); 7.79 dd, 1 H (H-3,
cyanophenyl); 7.92 m, 2 H (H-2, H-6, benzoyl).
N-[2-(4-Bromophenyl)-2-oxoethyl]-N-(2-cyanophenyl)-4-methylbenzenene-1-sulfonamide (10d).
Yield 40%; white crystals, m.p. 162-166 °C (ethanol). For C 22H17BrN2O3S (469.3) calculated:
56.30% C, 3.65% H, 17.02% Br, 5.97% N, 6.83% S; found: 55.99% C, 3.72% H, 16.85% Br,
5.86% N, 7.03% S. IR (KBr): 1 145, 1 352 (SO2); 1 694 (C=O); 2 235 (CN). 1H NMR (CDCl3):
2.44 s, 3 H (CH3); 5.17 s, 2 H (CH2); 7.26 m, 2 H (H-3, H-5); 7.31 t, 1 H, J = 7.8 (H-5,
cyanophenyl); 7.61 m, 6 H (H-2, H-6, H-3, H-4, cyanophenyl; H-2, H-6, benzoyl); 7.80 m,
3 H (H-6, cyanophenyl; H-3, H-5, benzoyl).
Method A. Sodium methoxide (55 mg, 1 mmol) was added to a stirred solution of 10 (1
mmol) in ethanol (5–20 ml) and the mixture was stirred at room temperature for 10 h. The
mixture was poured into water (25 ml), the insoluble portion was filtered off, washed with
water and crystallized from ethanol to give 4.
Method B. Triethylamine (0.2 g, 2 mmol) was added to a stirred solution of 10 (1 mmol)
in ethanol (5–20 ml) and the mixture was stirred at room temperature for 10 h. The mixture
was evaporated to dryness and crystallized from ethanol to give 4.
2-Benzoyl-1-(methanesulfonyl)indol-3-amine (4a). Yield 45% (Method A); yellow crystals,
m.p. 190–191 °C. For C 16H14N2O3S (314.4) calculated: 61.13% C, 4.49% H, 8.91% N, 10.20% S;
found: 60.68% C, 4.74% H, 8.57% N, 9.85% S. IR (KBr): 1 144, 1 339 (SO2); 1 631 (C=O); 3 333,
3 449 (NH2). UV, λ (log ε): 203 (4.44), 259 (4.08), 308 (3.67), 368 (4.13). 1H NMR (CDCl3):
2.43 s, 3 H (CH3); 6.01 bs, 2 H (NH2); 7.44 m, 4 H (H-4, H-5, H-6, H-4′); 7.62 m, 2 H (H-3′,
H-5′); 7.93 dd, 2 H, J = 7.6, 1.9 (H-2′, H-6′); 8.04 d, 1 H, J = 8.2 (H-7).
2-(4-Bromobenzoyl)-1-(methanesulfonyl)indol-3-amine (4b). Yield 59% (Method A); yellow
crystals, m.p. 208–212 °C. For C 16 H 13 BrN 2 O 3 S (393.2) calculated: 48.87% C, 3.33% H,
20.32% Br, 7.12% N, 8.15% S; found: 48.43% C, 3.11% H, 19.87% Br, 7.36% N, 8.43% S. IR
(KBr): 1 164, 1 345 (SO2); 1 620 (C=O); 3 349, 3 461 (NH2). UV, λ (log ε): 213 (4.41), 263
(4.24), 308 (3.80), 370 (4.19). 1H NMR (DMSO-d6): 2.51 s, 3 H (CH3); 7.16 bs, 2 H (NH2);
7.45 ddd, 1 H, J = 8.0, 7.3, 1.0 (H-6); 7.60 d, 2 H, J = 8.7 (H-3′, H-5′); 7.63 ddd, 1 H, J = 8.3,
7.3, 1.2 (H-5); 7.71 d, 2 H, J = 8.7 (H-2′, H-6′); 7.86 dt, 1 H, J = 8.3, 0.8 (H-4); 8.08 ddd, 1 H,
J = 8.0, 1.2, 0.8 (H-7).
2-Benzoyl-1-(4-methylbenzene-1-sulfonyl)indol-3-amine (4c). Yield 46% (Method A), 85%
(Method B); yellow crystals, m.p. 189–191 °C. For C 22H18N2O3S (390.5) calculated: 67.68% C,
4.65% H, 7.17% N, 8.21% S; found: 67.38% C, 4.84% H, 7.13% N, 8.08% S. IR (KBr): 1 172,
1 350 (SO2); 1 626 (C=O); 3 339, 3 449 (NH2). UV, λ (log ε): 203 (4.46), 257 (4.22), 308
(3.82), 372 (4.11). 1H NMR (CDCl3): 2.22 s, 3 H (CH3); 5.90 bs, 2 H (NH2); 6.96 d, 2 H, J = 8.0
(H-3, H-5, tosyl); 7.29 m, 4 H (H-4, H-5, H-2, H-6, tosyl); 7.49 m, 4 H (H-6, H-3′, H-4′, H-5′);
8.05 m, 2 H (H-2′, H-6′); 8.14 d, 1 H, J = 8.3 (H-7).
2-(4-Bromobenzoyl)-1-(4-methylbenzene-1-sulfonyl)indol-3-amine (4d). Yield 66% (Method A),
82% (Method B); yellow crystals, m.p. 187–195 °C. For C 22H17BrN2O3S (469.3) calculated:
56.30% C, 3.65% H, 17.02% Br, 5.97% N, 6.83% S; found: 55.87% C, 3.85% H, 16.77% Br,
5.77% N, 7.11% S. IR (KBr): 1 174, 1 355 (SO2); 1 623 (C=O); 3 333, 3 442 (NH2). UV, λ (log ε):
203 (4.56), 264 (4.31), 308 (3.71), 375 (4.10). 1H NMR (CDCl3): 2.23 s, 3 H (CH3); 5.93 bs,
2 H (NH2); 6.97 bd, 2 H, J = 8.3 (H-3, H-5, tosyl); 7.22–7.36 m, 4 H (H-5, H-6, H-2, H-6,
tosyl); 7.60 m, 3 H (H-7, H-3′, H-5′); 7.93 dt, 2 H, J = 8.6, 2.3 (H-2′, H-6′); 8.14 d, 1 H, J = 8.2
(H-7).
Sodium hydride (0.5 g, 50% dispersion in mineral oil, 10 mmol) was added to a solution of
2-aminobenzonitrile 9 (10 mmol) in DMF (30 ml) and the mixture was stirred for 1 h. Then
a solution of an appropriate 2-bromo-1-phenylethan-1-one 6 (10 mmol) was added and the mixture
was stirred at room temperature for 24 h. The mixture was poured into water (250 ml), the in-
soluble portion was filtered off, washed with water and crystallized from ethanol.
2-Benzoyl-1-(ethoxycarbonyl)indol-3-amine (4e). Yield 68%; yellow crystals, m.p. 129–131 °C
(ref. 18 131–133 °C). For C 18 H 16 N 2 O 3 (308.3) calculated: 70.12% C, 5.23% H, 9.09% N;
found: 69.98% C, 5.14% H, 8.68% N. IR (KBr): 1 612 (C=O); 1 726 (COO); 3 349, 3 467
(NH2). 1H NMR (CDCl3): 0.84 t, 3 H, J = 7.2 (CH3); 3.73 q, 2 H, J = 7.2 (CH2); 5.19 bs, 2 H
(NH2); 7.31 ddd, 1 H, J = 7.8, 7.2, 0.9 (H-4′); 7.38–7.48 m, 3 H (H-5, H-3′, H-5′); 7.55 ddd,
1 H, J = 8.4, 7.2, 1.2 (H-6); 7.62 ddd, 1 H, J = 7.8, 1.2, 0.8 (H-4); 7.76 m, 2 H (H-2′, H-6′);
8.21 dt, 1 H, J = 8.4, 0.8 (H-7).
2-(4-Bromobenzoyl)-1-(ethoxycarbonyl)indol-3-amine (4f).Yield 67%; yellow crystals, m.p.
118–120 °C. For C 18H15BrN2O3 (387.2) calculated: 55.83% C, 3.90% H, 20.63% Br, 7.23% N;
found: 55.52% C, 4.15% H, 21.17% Br, 6.93% N. IR (KBr): 1 612 (C=O); 1 722 (COO); 3 350,
3 390 (NH2). UV, λ (log ε): 213 (4.40), 263 (4.53), 308 (3.79), 370 (4.19). 1H NMR (CDCl3, 60 °C):
0.93 t, 3 H, J = 7.1 (CH3); 3.84 q, 2 H, J = 7.1 (CH2); 5.78 bs, 2 H (NH2); 7.31 bt, 1 H, J = 7.4
(H-5); 7.56 m, 6 H (H-4, H-6, benzoyl); 8.20 d, 1 H, J = 8.3 (H-7).
2-Benzoylindol-3-amine (11a)
A solution of sodium hydroxide (0.4 g, 10 mmol) in water (2 ml) was added to a stirred so-
lution of 4e (0.31 g, 1 mmol) in ethanol (3 ml) and the mixture was refluxed for 10 min.
The mixture was evaporated to dryness, the residue was triturated with water (5 ml) and ex-
tracted with dichloromethane (2 x 5 ml). The extract was washed with water to neutral reac-
tion of the aqueous layer and dried with magnesium sulfate. The residue after evaporation
was crystallized three times from hexane to give 11a as a brown solid (0.15 g, 63%); m.p.
51–52 °C. The compound darkens on light. For C 15H12N2O (236.3) calculated: 76.25% C,
5.12% H, 11.86% N; found: 76.26% C, 5.49% H, 11.45% N. 1H NMR (CDCl3): 5.57 bs, 2 H
(NH2); 7.06 dt, 1 H (H-7); 7.21 bd, 1 H, J = 8.4 (H-4); 7.35 dt, 1 H (H-5); 7.45–7.60 m, 5 H
(H-1, H-6, benzoyl); 7.82 m, 2 H (benzoyl).
2-(4-Bromobenzoyl)indol-3-amine (11b)
According to the procedure described for compound 11a, compound 11b was obtained from
4f as a brown solid (51%); m. p. 44–46 °C (cyclohexane). The compound darkens on light.
For C 15 H 11 BrN 2 O (315.2) calculated: 57.16% C, 3.52% H, 25.35% Br, 8.89% N; found:
57.55% C, 3.64% H, 24.97% Br, 8.63% N. IR (KBr): 1 599 (C=O); 3 319, 3 435 (NH2). UV, λ (log ε):
204 (4.74), 228 (4.23), 264 (4.29), 333 (4.20), 426 (3.91). 1H NMR (CDCl3): 5.53 bs, 2 H
(NH2); 7.04 dt, 1 H, J = 8.0, 0.8 (H-7); 7.22 m, 1 H (H-4); 7.35 dt, 1 H, J = 8.1, 0.8 (H-5);
7.55–7.70 m, 6 H (H-1, H-6, benzoyl).
Biological Evaluation
Hot-Plate Test
The hot-plate test was used to measure the response latencies according to the method de-
scribed earlier28, with minor modifications. All animals (male NMRI mice) were selected on
the basis of their reactivity in the model. The selected animals were placed into a glass cyl-
inder and the plate temperature was maintained at 54 °C. The time necessary to induce the
licking reflex of the forepaws or jumping was recorded. The measurement was done 30 and
60 min after administration of 30 mg/kg of the tested compound and the results were ex-
pressed as prolongation of the licking latencies (%).
Writhing was induced by intraperitoneal injection of 0.2 ml of 0.7% solution of acetic acid
to male NMRI mice 30 min after the administration of 30 mg/kg of the tested compound29.
Writhings were counted for 20 min, compared with the control and expressed as decrease in
the stretching movements (%).
Tail-Flick Test
A slightly modified method of D’Amour and Smith 30 was used. The animals (male
Wistar–Hannover rats) were placed in a Ugo Basile (Varese, Italy) apparatus and the predrug
latency to removal of the tail from a radiant heat source (light beam focused 3 cm from the
end of the tail) was determined twice for each rat. The animals were then administered the
appropriate tested compound (30 mg/kg) and were placed in the holding apparatus. Thirty
and sixty minutes later, a postdrug latency was measured. A postdrug latency was expressed
as a decrease in latency of the control (%).
The authors are indebted to T. Pilarčík and M. Bartůněk for the NMR, and Ms M. Švorčíková for the
UV and IR measurements. This work was supported by the Grant Agency of the Ministry of Industry
and Trade of the Czech Republic (grant No. PP-Z1/08) and by Léčiva Co. Praha.
REFERENCES
1. Vaz Z. R., Cechinel-Filho V., Yunes R. A., Calixto J. B.: J. Pharmacol. Exp. Ther. 1996, 278,
304.
2. Cechinel-Filho V., Vaz Z. R., Zunino L., Calixto J. B., Yunes R. A.: Eur. J. Med. Chem.
1996, 31, 833.
3. Livingstone R. in: Rodd’s Chemistry of Carbon Compounds (S. Coffey, Ed.), Vol. IV, Part A,
p. 83. Elsevier, Amsterdam 1973.
4. Mackenzie J. B. D., Robertson A., Bushra A., Towcis R.: J. Chem. Soc. 1949, 2057.
5. Hirota T., Fujita H., Sasaki K., Namba T., Hayakawa S.: Heterocycles 1986, 24, 771.
6. Bisagni M., Buu-Hoi N. P., Royer R.: J. Chem. Soc. 1955, 3693.
7. Sonn A., Bülow W.: Chem. Ber. 1925, 58, 1691.
8. Dean F. M., Robertson A.: J. Chem. Soc. 1953, 1241.
9. Srivastava S. D., Srivastava S. K.: Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.
1987, 26, 57.
10. Malterud K. E., Undheim J., Erdal J. E.: Tetrahedron Lett. 1985, 26, 4807.
11. Gillies I., Loft M.: Synth. Commun. 1988, 18, 191.
12. Gewald K., Jansch H.-J.: J. Prakt. Chem. 1973, 315, 779.
13. Vaidya V. P., Mahajan S. B., Agasimundin Y. S. : Indian J. Chem., Sect. B: Org. Chem. Incl.
Med. Chem. 1981, 20, 391.
14. Rahman L. K. A., Scrowton R. M.: J. Chem. Soc., Perkin Trans. 1 1983, 2973.
15. Carrington D. E. L., Clarke K., Scrowston R. M.: J. Chem. Soc. C 1971, 3903.
16. Beck J. R.: J. Heterocycl. Chem. 1978, 15, 513.
17. Beugelmans R., Bois-Choussy M., Boudet B.: Tetrahedron 1983, 39, 4153.
18. Garcia E. E., Benjamin L. E., Fryer R. I.: J. Heterocycl. Chem. 1973, 10, 51.
19. Pirkle W. H., Simmons K. A.: J. Org. Chem. 1983, 48, 2520.
20. Fišnerová L., Brůnová B., Kocfeldová Z., Tíkalová J., Matunová E., Grimová J.: Collect.
Czech. Chem. Commun. 1991, 56, 2373.
21. Abramovitch R. A., Knaus G. N., Uma V.: J. Org. Chem. 1974, 39, 1101.
22. Auwers K.: Chem. Ber. 1925, 58, 2081.
23. Schroeder H. E., Rigby G. W.: J. Am. Chem. Soc. 1949, 71, 2205.
24. Auwers K., Frese E.: Justus Liebigs Ann. Chem. 1926, 450, 273.
25. Brandt E. V., Ferreira D., Roux D. G.: J. Chem. Soc., Perkin Trans. 1 1981, 514.
26. Borsche W., Hahn-Weinheimer P.: Justus Liebigs Ann. Chem. 1950, 570.
27. Bates D. K.: J. Org. Chem. 1977, 42, 3452.
28. Eddy N. B., Leimbach D.: J. Pharmacol. Exp. Ther. 1953, 80, 385.
29. Koster R., Anderson M., De Beer J.: Fed. Proc. 1959, 18, 412.
30. D’Amour F. E., Smith D. L. J.: Pharmacol. Exp. Ther. 1941, 72, 74.
The author has requested enhancement of the downloaded file. All in-text references underlined in blue are linked to publications on ResearchGate.